Table 4. Adjusted Cox regression analysis: ANXA10 expression and the presence of SSP on follow-up.
| Adjusted fora |
High vs. low ANXA10 expression |
|
|---|---|---|
| HR (95% CI) | Pvaluea | |
| Female | 2.97 (1.10, 8.04) | 0.032 |
| Age | 3.51 (1.19, 10.37) | 0.023 |
| Smoking | 3.13 (1.16, 8.44) | 0.024 |
| Family history of cancer | 2.90 (1.08, 7.81) | 0.035 |
| Original SSP diagnosis on baseline scope | 2.7 (0.98, 7.3) | 0.054 |
| Revised SSP diagnosis on baseline scope | 2.45 (0.85, 7.10) | 0.098 |
ANXA10, Annexin 10; CI, confidence interval; HR, hazard ratio; SSP, sessile serrated polyp.
a
Six separate Cox regression models were built; occurrence of follow-up SSP was modeled as the outcome with high vs. low ANXA10 expression and each confounder (one at a time) as the independent variable.